PSMA therapy is a targeted treatment for metastatic prostate cancer that uses radioligand therapy to slow disease progression ...
Know the questions to ask your doctor about metastatic prostate cancer, such as treatment options, lifestyle changes, and ...
Oncology Research Program ( ORP) today announced funding awards for quality improvement initiatives in metastatic prostate ...
Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity.
Major technological advances have been made in imaging, especially in the quality of the resolution or detail.
Opevesostat (Merck). A first-in-class CYP11A1 inhibitor that shuts down androgen production at its source, opevesostat is in two phase 3 trials, OMAHA-003 and OMAHA-004, for metastatic ...
A medical oncologist at the Mayo Clinic who treats patients with prostate cancer shares the warning signs he looks for his ...